Asacol Enema 2g Rectal suspension
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate ulcerative colitis and Crohn's disease.
Dosage (summary)
1 enema (2 g) administered rectally once daily, preferably at bedtime.
Onset of Action / Duration
Symptomatic relief may be observed within 1 to 2 weeks, but full therapeutic effect may take up to 4 to 6 weeks.
Special Populations
- Elderly patients
- Patients with renal impairment
- Patients with hepatic impairment
Pregnancy & Breastfeeding
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Mesalazine is excreted in breast milk; caution is advised.
Key Drug Interactions
- May enhance the effects of anticoagulants.
- Caution with other nephrotoxic agents.
Contraindications
- Hypersensitivity to mesalazine or any component of the formulation.
- Severe renal impairment.
Common side effects
- Abdominal pain
- Diarrhea
- Nausea
- Headache
- Rash
Counselling Points
- Instruct patients to retain the enema for as long as possible for maximum effect.
- Advise patients to report any signs of allergic reactions, such as rash or difficulty breathing.
- Encourage adherence to the prescribed dosage regimen.
Serious warnings
- Monitor renal function regularly during treatment.
- Use with caution in patients with a history of gastrointestinal obstruction or severe liver disease.
Important Disclaimer
The Asacol Enema 2g Rectal suspension professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
